About Aquestive Therapeutics
A pharmaceutical company advancing medicines to solve patients’ problems with current standards of care.
- Industry
- Pharmaceutical Manufacturing
- Company size
- 51-200 employees
- Headquarters
- Warren, New Jersey
- Company type
- Public Company
Aquestive Therapeutics, Inc. (NASDAQ: AQST) is a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative science and delivery technologies. We are developing orally administered products to deliver complex molecules, providing novel alternatives to invasive and inconvenient standard of care therapies.
Aquestive has four licensed commercialized products marketed by its licensees in the U.S. and around the world and is the exclusive manufacturer of these licensed products. The Company also collaborates with pharmaceutical companies to bring new molecules to market using proprietary, best-in-class technologies, like PharmFilm®, and has proven drug development and commercialization capabilities.
Aquestive is advancing a late-stage proprietary product candidate for the treatment of severe allergic reactions, including anaphylaxis, and an early-stage epinephrine prodrug topical gel product candidate for various possible dermatological conditions, including alopecia areata.
Company locations
30 Technology Drive, Warren, New Jersey 07059, US
Locations listed on the company profile. These may include offices outside the United States, and not every location is hiring.
Business areas
- Pharmaceutical
On LinkedIn
- Followers
- 12,110
- People linked to this company
- 148
People who list this company on LinkedIn, not a verified employee count. Figures reflect the saved company profile.
Funding raised
603,063,956 USD
Total reported by Crunchbase, in US dollars. This is funding raised, not company revenue or valuation.
Explore the company
Employer category
Other employer
Estimated from the company profile. This category has not been confirmed by the employer.